Skip to content

Xerox Holdings Corporation XRX Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Other financials

Income statement

See full
Revenue$1.8B+26.7%
Gross profit$72.0M+227%
Net income-$105.0M-16.7%
EPS (diluted)-$0.84-12.0%

Balance sheet

See full
Cash & equivalents$637.0M+63.3%
Total debt$4.4B+52.4%
Total equity$299.0M-71.6%
Total assets$9.9B+20.6%

Cash flow

See full
Operating cash flow-$144.0M-61.8%
CapEx$12.0M+140%
Free cash flow-$156.0M-66.0%

Valuation

See full
Market cap$421.11M-37.7%
Enterprise value$4.23B+32.1%
P/S0.1×-0.1×

Profitability

See full
Gross margin3.9%-1.5pp
Net margin-14.1%-3.5pp
FCF margin8.1%+1.8pp

Returns & leverage

See full
Return on equity-154.4%-3,910pp
Debt / equity14.9×+12.1×
Current ratio1.2×+0.1×